Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11010-021-04204-3 http://scihub22266oqcxt.onion/10.1007/s11010-021-04204-3 34110554!8190527!34110554     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Cell+Biochem 2021 ; 476 (10): 3815-3825 Nephropedia Template TP {{tp|p=34110554|t=2021. Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation |pdf=|usr=}}{{34110554}} gab.com Text Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation JO: Mol Cell Biochem http://www.kidney.de/pget.php?&tw=1&pmid=34110554 #FOAvip Chagas and COVID-19 are diseases caused by Trypanosoma cruzi and SARS-CoV-2, respectively. These diseases present very different etiological agents despite showing similarities such as susceptibility/risk factors, pathogen-associated molecular patterns (PAMPs), recognition of glycosaminoglycans, inflammation, vascular leakage hypercoagulability, microthrombosis, and endotheliopathy; all of which suggest, in part, treatments with similar principles. Here, both diseases are compared, focusing mainly on the characteristics related to dysregulated immunothrombosis. Given the in-depth investigation of molecules and mechanisms related to microthrombosis in COVID-19, it is necessary to reconsider a prompt treatment of Chagas disease with oral anticoagulants. Twit Text FOAVip Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation ????Mol Cell Biochem http://www.kidney.de/pget.php?&tw=1&pmid=34110554 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34110554 #FOAvip English Wikipedia <ref>{{Cite pmid|34110554}}</ref> Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation #MMPMID34110554 Perez-Campos Mayoral L; Hernandez-Huerta MT; Papy-Garcia D; Barritault D; Zenteno E; Sanchez Navarro LM; Perez-Campos Mayoral E; Matias Cervantes CA; Martinez Cruz M; Mayoral Andrade G; Lopez Cervantes M; Vazquez Martinez G; Lopez Sanchez C; Pina Canseco S; Martinez Cruz R; Perez-Campos E Mol Cell Biochem 2021[Oct]; 476 (10): 3815-3825 PMID34110554show ga Chagas and COVID-19 are diseases caused by Trypanosoma cruzi and SARS-CoV-2, respectively. These diseases present very different etiological agents despite showing similarities such as susceptibility/risk factors, pathogen-associated molecular patterns (PAMPs), recognition of glycosaminoglycans, inflammation, vascular leakage hypercoagulability, microthrombosis, and endotheliopathy; all of which suggest, in part, treatments with similar principles. Here, both diseases are compared, focusing mainly on the characteristics related to dysregulated immunothrombosis. Given the in-depth investigation of molecules and mechanisms related to microthrombosis in COVID-19, it is necessary to reconsider a prompt treatment of Chagas disease with oral anticoagulants. |Anticoagulants/*therapeutic use[MESH] |Blood Platelets/immunology[MESH] |COVID-19/immunology/*pathology[MESH] |Chagas Disease/immunology/*pathology[MESH] |Complement Activation/immunology[MESH] |Endothelium/pathology[MESH] |Heparitin Sulfate/*therapeutic use[MESH] |Humans[MESH] |Pathogen-Associated Molecular Pattern Molecules/immunology[MESH] |Platelet Activation/immunology[MESH] |SARS-CoV-2/immunology[MESH] |Thrombosis/*drug therapy/*pathology[MESH]Immunothrombotic dysregulation in chagas disease and COVID-19: a compa(epmc).pdf DeepDyve Pubget Overpricing